Medicare Enrolled
Dr. David Amran, M.D.
Allergy & Immunology · Sugar Land, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Amran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amran
Dr. David Amran is an allergy & immunology specialist in Sugar Land, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Amran performed 105,651 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Amran received a total of $97,011 from 49 pharmaceutical and/or device companies across 936 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 1% volume in TX
$97,011 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗105,651
Medicare services
Top 1% in TX for allergy & immunology
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Omalizumab injection (Xolair) for asthma/allergy | 34,577 | $30 | $42 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 24,923 | $38 | $115 |
| Injection, mepolizumab, 1 mg | 20,201 | $22 | $57 |
| Allergy immunotherapy preparation A professional service involving the preparation and administration of one or more antigens. |
7,870 | $11 | $15 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
6,976 | $3 | $15 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
3,175 | $8 | $32 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,488 | $11 | $150 |
| Skin allergy test A test where small amounts of potential allergens are injected into the skin to check for allergic reactions. |
1,338 | $6 | $13 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
1,100 | $16 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,014 | $66 | $135 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
601 | $29 | $175 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
504 | $49 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
318 | $42 | $82 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
295 | $20 | $110 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
269 | $14 | $32 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
157 | $7 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
154 | $92 | $194 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
101 | $8 | $15 |
| Airway resistance test at varying frequencies A test that measures how much resistance the airways and lungs offer to airflow at different frequencies. |
80 | $29 | $325 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
79 | $41 | $270 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
78 | $43 | $120 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
68 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
67 | $68 | $70 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
43 | $45 | $150 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
40 | $16 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $121 | $250 |
| Levalbuterol inhalation solution, 0.5 mg A 0.5 mg unit dose of FDA-approved levalbuterol inhalation solution administered via durable medical equipment. |
24 | $0 | $10 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
21 | $41 | $60 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
19 | $29 | $30 |
| New patient office visit, complex (60-74 min) | 15 | $163 | $393 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
14 | $131 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $80 | $188 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.5% high complexity
79.9% medium
18.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$97,011
Total received (2018-2024)
Avg $13,859/year across 7 years
Top 6% in TX for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
936
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,188
2023
$11,591
2022
$18,824
2021
$34,344
2020
$11,733
2019
$5,907
2018
$3,424
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$4,838
GlaxoSmithKline, LLC.
$3,230
GENZYME CORPORATION
$678
Takeda Pharmaceuticals U.S.A., Inc.
$314
PFIZER INC.
$207
Regeneron Healthcare Solutions, Inc.
$200
Genentech USA, Inc.
$200
LEO Pharma Inc.
$171
Pharming Healthcare, Inc.
$161
Amgen Inc.
$141
Grifols USA, LLC
$139
ABBVIE INC.
$115
Novartis Pharmaceuticals Corporation
$111
SANOFI-AVENTIS U.S. LLC
$95
kaleo, Inc.
$80
Blueprint Medicines Corporation
$76
CSL Behring
$72
HOSPIRA, INC.
$61
TerSera Therapeutics LLC
$50
Optinose US, Inc.
$46
Incyte Corporation
$44
Galderma Laboratories, L.P.
$30
Cycle Pharmaceuticals Inc
$26
X4 Pharmaceuticals, Inc.
$20
Hikma Pharmaceuticals USA
$19
BioCryst US Sales Co., LLC
$18
Insmed, Inc.
$15
Lilly USA, LLC
$15
Aytu BioPharma, Inc.
$14
Top 3 companies account for 78.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$69,307
AstraZeneca Pharmaceuticals LP
$7,279
Novartis Pharmaceuticals Corporation
$6,562
Regeneron Healthcare Solutions, Inc.
$3,598
GENZYME CORPORATION
$2,404
PFIZER INC.
$663
Takeda Pharmaceuticals U.S.A., Inc.
$538
Genentech USA, Inc.
$522
kaleo, Inc.
$516
Amgen Inc.
$471
ABBVIE INC.
$442
Grifols USA, LLC
$440
Teva Pharmaceuticals USA, Inc.
$416
Optinose US, Inc.
$416
Pharming Healthcare, Inc.
$402
LEO Pharma Inc.
$354
SANOFI-AVENTIS U.S. LLC
$266
OptiNose US, Inc.
$261
Octapharma USA, Inc.
$217
Incyte Corporation
$216
Boehringer Ingelheim Pharmaceuticals, Inc.
$203
AbbVie Inc.
$189
CSL Behring
$145
Mylan Specialty L.P.
$142
Blueprint Medicines Corporation
$138
Shire North American Group Inc
$119
SANOFI PASTEUR INC.
$111
Kaleo, Inc.
$68
ALK-Abello, Inc
$66
HOSPIRA, INC.
$61
TerSera Therapeutics LLC
$50
AbbVie, Inc.
$44
Hikma Pharmaceuticals USA
$40
BioCryst US Sales Co., LLC
$37
ADMA BioManufacturing LLC
$31
Galderma Laboratories, L.P.
$30
Cycle Pharmaceuticals Inc
$26
Pulmonx Corporation
$25
Xeris Pharmaceuticals, Inc.
$21
X4 Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme LLC
$20
Horizon Pharma plc
$20
Horizon Therapeutics plc
$19
Philips Electronics North America Corporation
$19
Phadia US Inc.
$17
Insmed, Inc.
$15
Lilly USA, LLC
$15
Aytu BioPharma, Inc.
$14
Aytu Bioscience, Inc
$14
Top 3 companies account for 85.7% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADACEL · ADBRY · AIRSUPRA · AKLIEF · AREXVY · AUVI-Q · AYVAKIT · Aciphex · AirDuo Digihaler · Arikayce · Auvi-Q · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CIBINQO · CINQAIR · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EBGLYSS · EOHILIA · EUCRISA · EVUSHELD · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · GVOKE HYPOPEN · Gamunex-C · HYQVIA · Haegarda · Hizentra · ImmunoCAP · Karbinal · NO PRODUCT DISCUSSED · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · PANZYGA · PREVNAR 20 · ProAir Digihaler · QVAR · Quzyttir · RINVOQ · RUCONEST · Ryaltris · SHINGRIX · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Sajazir · Skyrizi · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · XOLAIR · XOLREMDI · Xembify · Xhance · Xofluza · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Allergy & immunologists in nearby ZIP areas
50
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Amran is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Amran experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Amran performed 34,577 omalizumab injection (xolair) for asthma/allergy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Amran receive payments from pharmaceutical companies?
Yes. Dr. Amran received a total of $97,011 from 49 companies across 936 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amran's costs compare to other allergy & immunologists in Sugar Land?
Dr. Amran's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Allergy & Immunologists in Sugar Land
Browse allergy & immunologists in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Allergy & Immunologists in TX
Allergy & immunologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Allergy & Immunologists in TX
Which TX allergy & immunologists receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology